A novel RFLP-ARMS TaqMan PCR-based method for detecting the BRAF V600E mutation in melanoma

Oncol Lett. 2018 Aug;16(2):1615-1621. doi: 10.3892/ol.2018.8844. Epub 2018 May 30.

Abstract

To enable the rapid and sensitive screening of the BRAF V600E mutation in clinical samples, a novel method combining restriction fragment length polymorphism (RFLP) analysis with the popular amplification refractory mutation system (ARMS) TaqMan quantitative (qPCR) genotyping method in a single reaction tube was developed. A total of 2 primer pairs were designed to enrich for and genotype the BRAF mutational hotspot (RFLP primers and ARMS primers) and a restriction enzyme was used to remove the wild-type alleles. The analysis revealed that this method detected mutant alleles in mixed samples containing >0.1% mutant sequences. In a survey of 53 melanoma samples, this method detected 21 mutation-positive samples. This novel RFLP-ARMS TaqMan qPCR protocol may prove useful for detecting mutations in clinical samples containing only a small proportion of mutant alleles.

Keywords: B-Raf proto-oncogene; V600E; melanoma; restriction fragment length polymorphism-amplification refractory mutation system TaqMan polymerase chain reaction; serine/threonine kinase.